Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1191
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2020  |  Volume : 68  |  Issue : 11  |  Page : 2466-2470

Malignant tumors of the eyelid in India: A multicenter, multizone study on clinicopathologic features and outcomes


1 Department of Orbit, Oculoplasty and Ocular Oncology, Narayana Nethralaya, Bangalore, Karnataka, India
2 Department of Orbit, Oculoplasty and Ocular Oncology, Calcutta Medical Research Institute, Kolkata, West Bengal, India
3 Department of Orbit, Oculoplasty and Ocular Oncology, Hinduja Hospital, Mumbai, Maharashtra, India
4 Department of Orbit Oculoplasty and Ocular Oncology, Shroff Charity Eye Hospital, New Delhi, India
5 Department of Orbit, Oculoplasty and Ocular Oncology, Center for Sight, New Delhi, India

Correspondence Address:
Dr. Roshmi Gupta
Orbit, Oculoplasty and Ocular Oncology Services, Narayana Nethralaya, 121/C Chord Road, Rajajinagar 1st R Block, Bangalore - 560 010, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijo.IJO_2306_19

Rights and Permissions

Purpose: To analyze data on eyelid malignancy in India, clinical and pathologic features, and outcomes. Methods: A multicentre study, from oculoplastic practices in four geographic zones in India. The centers perform similar documentation and protocol-based management for eyelid tumors. Clinical features, pathology, American Joint Committee on Cancer (AJCC) class, management, and the outcomes were analyzed. Results: The study included 129 patients, with slight female preponderance and mean age 62.7 years. The median delay to the consultation was 9 months. Rural patients traveled a mean distance of 115.2 km; there was no difference between the city and outstation patients in the delay to consultation or follow up. Pathology included 55/129 (42.6%) sebaceous gland carcinoma (SGC), 47/129 (36.4%) basal cell carcinoma (BCC), squamous cell carcinoma (SCC) in 15 (11.6%), and 12 (9.3%) other tumors. Commonest AJCC class was T2b/T3a in 80/111 (72%), invasion of the orbit was present in 16 (12.4%). Surgery with margin clearance was performed in 103. With a mean follow-up of 21.44 months, local recurrence and/or metastasis were seen in 12%. The diagnosis of SGC was strongly associated with adverse outcomes (odds ratio: 7.36). On multiple logistic regression analysis, diagnosis of SGC (P = 0.011) was significant in having adverse outcomes. Conclusion: The multicenter Indian data shows the highest prevalence of SGC, with the commonest AJCC class T2b. Most tumors were locally resectable at presentation. The histopathologic diagnosis of SGC is the factor strongly associated with adverse outcomes.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed419    
    Printed0    
    Emailed0    
    PDF Downloaded69    
    Comments [Add]    

Recommend this journal